Elizabeth A. Barrett's Net Worth
$4.23 Million
Who is Elizabeth A. Barrett?
Elizabeth A. Barrett has an estimated net worth of $4.23 Million. This is based on reported shares across multiple companies, which include UroGen Pharma Ltd., Allogene Therapeutics, Inc., and Lifesci Acquisition II Corp..
SEC CIK
Elizabeth A. Barrett's CIK is 0001764157
Past Insider Trading and Trends
2020 was Elizabeth A. Barrett's most active year for acquiring shares with 17 total transactions. Elizabeth A. Barrett's most active month to acquire stocks was the month of December. 2020 was Elizabeth A. Barrett's most active year for disposing of shares, totalling 14 transactions. Elizabeth A. Barrett's most active month to dispose stocks was the month of December. 2019 saw Elizabeth A. Barrett paying a total of $460,248.00 for 16,548 shares, this is the most they've acquired in one year. In 2022 Elizabeth A. Barrett cashed out on 179,185 shares for a total of $491,875.30, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
UroGen Pharma Ltd. (URGN) Snapshot price: $13.23
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +5.95% | 18.33K |
—
|
—
| 326.69K |
Jan 31
| |||
Form 4
| +3.40% | 10.14K |
$7.58 | -$62,118.10 | 308.36K |
Jan 31
| |||
Form 4
| +24.52% | 58.72K |
$9.15 | -$429,757.20 | 298.22K |
Jan 3 - Jan 4
| |||
Form 4/A
| +39.15% | 61.65K |
—
|
—
| 219.12K |
Jun 3 - Dec 3
| |||
Form 4/A
| +28.82% | 35.23K |
—
|
—
| 157.47K |
Feb 3 - May 3
| |||
Form 4
| +4.53% | 10.38K |
$17.51 | -$59,967.98 | 239.5K |
Jan 3 - May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +4.56% | 10K |
$18.50 | $185,000.00 | 229.12K |
Dec 14
| |||
Form 4
| +39.15% | 61.65K |
—
|
—
| 219.12K |
Dec 4
| |||
Form 4
| +28.82% | 35.23K |
—
|
—
| 157.47K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +638.68% | 105.69K |
—
|
—
| 122.24K |
Jan 3
| |||
Form 4
| +83.50% | 7.53K |
$28.00 | $210,840.00 | 16.55K |
Nov 21
| |||
Form 4
| +482.56% | 7.47K |
$28.00 | $209,160.00 | 9.02K |
Nov 20
| |||
Form 4
|
∞
| 1.55K |
$26.00 | $40,248.00 | 1.55K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allogene Therapeutics, Inc. (ALLO) Snapshot price: $2.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lifesci Acquisition II Corp. (SNCE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||